Opko Health (OPK)

• Market cap: $1.05B
• 1 day: -0.75%
• 5 days: -3.62%
• 1 month: 2.31%
• 3 months: -22.67%
• 6 months: -16.35%
• Year to date: -8.28%
• 1 year: 3.91%
• 5 years: -48.85%
• 10 years: -91.37%
• Sector: Healthcare
• Industry: Diagnostics & Research

About: OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.

Employees: 2,997

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

490% more call options, than puts

Call options by funds: $5.14M | Put options by funds: $870K

79% more first-time investments, than exits

New positions opened: 43 | Existing positions closed: 24

38% more capital invested

Capital invested by funds: $290M [Q4 2024] → $401M (+$110M) [Q1 2025]

36% more repeat investments, than reductions

Existing positions increased: 76 | Existing positions reduced: 56

8% more funds holding

Funds holding: 232 [Q4 2024] → 250 (+18) [Q1 2025]

7.03% more ownership

Funds ownership: 28.94% [Q4 2024] → 35.97% (+7.03%) [Q1 2025]

Research analyst outlook

2 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $2.25 69% upside
• Avg. target: $2.63 97% upside
• High target: $3 126% upside

2 analyst ratings

• positive: 2 100%
• neutral: 0 0%
• negative: 0 0%

Barrington Research Michael Petusky	69% upside $2.25	Outperform Maintained	1 May 2025
HC Wainwright & Co. Yi Chen	126% upside $3	Buy Reiterated	7 Apr 2025